DRUG CONSUMPTION ROOMS Around the World

Drug Consumption Rooms are safe spaces where people can use drugs under hygienic conditions, with support, and without fear of violence or legal repercussions. Today, more than 140 legally-sanctioned DCRs operate in 11 European countries, as well as in Australia, Canada, Mexico and the USA. Join us on a global video tour to discover why they were established, how they support their local communities and how these life-saving harm reduction facilities have evolved over time. Watch the full film co-produced by Drugreporter and Correlation - European Harm Reduction Network here:

The full film

You can turn on English subtitles at the bottom right of the YouTube window.

Narrator: Roberto Perez Gayo
Video and editing: István Gábor Takács
Narration text: Roberto Perez Gayo and István Gábor Takács

What are drug consumption rooms?

As the newly published Policy & Advocacy Brief on Drug Consumption rooms by Correlation - European Harm Reduction Network describes: "Drug Consumption Rooms are commonly defined as services where people can use pre-obtained drugs under hygienic conditions, with professional support, and in a safe environment without fear of violence, arrest or legal repercussions.

As part of these services, trained staff intervene in the event of a drug-related overdose or other medical complications and provide education on safer use practices. DCRs also supply equipment for drug use and a wide range of other services, including social, medical and mental health care and support, either onsite or through a referral system.

The primary concern and goal of DCRs is that of supporting the health and well-being of people who use drugs; for instance, by preventing overdose mortality, providing primary physical and mental healthcare, reducing transmission of communicable diseases and enabling testing.

Not only are DCRs successful health interventions, but they also have a positive impact on wider healthcare by decreasing the strain on ambulance services and in reducing long-term health consequences and costs.

DCRs minimise risks and harms resulting from the ‘risk environments’ that people who use drugs experience as a consequence of physical, social, economic and policy factors while additionally reducing drug use in public spaces and perceived public nuisance.

While these aims are fundamental, the harm reduction potential of DCRs is not only limited to offering a space to safely use drugs and to reduce drug use in public. Low-threshold DCRs also promote voluntary access to other types of support (health, housing, social, economic, and legal services) which might otherwise be too high- threshold for their clients to access."

You can read the full report, titled: "Creating Safer Consumption Spaces in Europe: Evolving Contexts and Implications for Policy" below:

More resources on Drug Consumption Rooms

A main aim of this report by the EMCDDA and C-EHRN is to inform discussions on drug consumption rooms (DCRs) by examining the available evidence, as well as reviewing the various models being adopted and their characteristics.

This page by the European Union Drugs Agency provides an overview of key issues related to drug consumption rooms, including service delivery, guidance and existing evidence and latest developments in Europe. It also considers implications for policy and practice.

The study aims to provide an overview of the range, scope and structure of care services for people who use drugs currently provided by drug consumption rooms in Europe.

Supported by

Picture 1

This video has been co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.

dcr 1080

Drug Consumption Rooms  - Around the World